Related Experiment Videos
[Blood component transfusion in Croatia]
Bilten Za Hematologiju I Transfuziju
|January 1, 1978
Summary
Blood component therapy offers better patient outcomes, safety, and economy. To meet demand, Croatia needs more blood donations and increased use of blood component therapy.
Area of Science:
- Hematology
- Transfusion Medicine
Context:
- Blood component therapy is globally accepted for its efficacy, safety, and cost-effectiveness.
- In SRH (Socialist Republic of Croatia), adoption of blood component therapy lags behind global trends, evidenced by slow production and utilization of blood derivatives over a five-year period (1974-1978).
- Despite an increase in blood donations to 27 per 1,000 inhabitants, this figure remains significantly below the optimal range of 40-60 donations per 1,000 inhabitants.
Purpose:
- To assess the production and utilization of blood derivatives in SRH between 1974 and 1978.
- To evaluate the sufficiency of current blood derivative quantities to meet healthcare demands.
- To identify strategies for increasing blood plasma availability and optimizing blood component therapy implementation.
Summary:
- Production of albumin, immunoglobulins, and Factor VIII saw substantial increases (5-10 fold) during 1974-1978.
- In 1978, per 1,000 inhabitants, 2.1 L of plasma were fractionated, with 53g albumin and 23ml immunoglobulins used, alongside 6,200 units for hemophiliacs.
- These quantities were insufficient to meet the healthcare service needs in SRH.
Impact:
- The study highlights a critical shortage of essential blood derivatives in SRH.
- Recommendations include increasing blood donation rates, raising average donation volume to 450ml, expanding plasmapheresis, and scaling up blood component therapy.
- Achieving 10-12 L of plasma for fractionation per 1,000 inhabitants is crucial for securing optimal derivative quantities.